The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...

Thousands of Rhode Island seniors and disabled residents no longer covered for non-emergency visits at four local hospitals ...

The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

DHS Temporary Commissioner Shireen Gandhi on Friday made a request of the federal Centers for Medicare and Medicaid Services ...

State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so. Meanwhile, Medicare currently covers GLP-1 drugs for people with a ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

A new rule issued by the Centers for Medicare and Medicaid Services will strip DACA recipients of eligibility for coverage under Affordable Care Act effective August 31.

The Trump administration, CMS, and over 60 companies including Apple have announced a new nationwide digital health ecosystem ...

A major cybersecurity incident has exposed sensitive personal and health records of tens of thousands of Americans.

The Centers for Medicare & Medicaid Services awarded the Department of Public Health and Social Services $39 million for the ...

The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...